Beta Bionics, Inc. (BBNX) › Cash & EquivalentsBeta Bionics, Inc. (BBNX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $26.57M2024: $30.43M2025: $31.58M$31.58M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$31.58M+3.8%2024$30.43M+14.6%2023$26.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share